Earnings Call · Q1 FY2026·2026-05-13

Q1 26EPS -11.76%·Rev n/aQ4 25EPS +40.00%·Rev n/aQ3 25EPS -50.00%·Rev n/aQ2 25EPS +5.71%·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

Derek Cole — Investor Relations

Stephen Willard — Chief Executive Officer

Nataliya Agafonova — Chief Medical Officer

Lisa Locklear — Chief Financial Officer

Joshua Hare — Chief Scientific Officer

+0.7%1d on move date+0.1% vs SPY3d−10.5%5d−10.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access